A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.

about

A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.

Item

http://www.wikidata.org/entity/Q55348052

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

A versatile T cell-based assay ...... ific PD-1-targeted approaches.

@en

A versatile T cell-based assay ...... ific PD-1-targeted approaches.

@nl

type

Item

label

A versatile T cell-based assay ...... ific PD-1-targeted approaches.

@en

A versatile T cell-based assay ...... ific PD-1-targeted approaches.

@nl

prefLabel

A versatile T cell-based assay ...... ific PD-1-targeted approaches.

@en

A versatile T cell-based assay ...... ific PD-1-targeted approaches.

@nl

P1476

A versatile T cell-based assay ...... cific PD-1-targeted approaches

@en

P2093

Fumihiro Fujiki

http://www.w3.org/2001/XMLSchema#string

Hans De Reu

http://www.w3.org/2001/XMLSchema#string

Haruo Sugiyama

http://www.w3.org/2001/XMLSchema#string

Johan M J Van den Bergh

http://www.w3.org/2001/XMLSchema#string

Soyoko Morimoto

http://www.w3.org/2001/XMLSchema#string

Viggo F I Van Tendeloo

http://www.w3.org/2001/XMLSchema#string

P2860

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

NFAM1, an immunoreceptor tyrosine-based activation motif-bearing molecule that regulates B cell development and signaling

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis.

The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation

PD-L1 and Survival in Solid Tumors: A Meta-Analysis

PD-1 and its ligands in tolerance and immunity

PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells

Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1)

Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2.

P304

27797-27808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.25591

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29963238

http://www.w3.org/2001/XMLSchema#string

P932

6021243

http://www.w3.org/2001/XMLSchema#string